Paul M. O’Byrne

55.2k total citations · 16 hit papers
556 papers, 38.1k citations indexed

About

Paul M. O’Byrne is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Paul M. O’Byrne has authored 556 papers receiving a total of 38.1k indexed citations (citations by other indexed papers that have themselves been cited), including 464 papers in Physiology, 343 papers in Pulmonary and Respiratory Medicine and 156 papers in Immunology and Allergy. Recurrent topics in Paul M. O’Byrne's work include Asthma and respiratory diseases (462 papers), Respiratory and Cough-Related Research (239 papers) and Allergic Rhinitis and Sensitization (152 papers). Paul M. O’Byrne is often cited by papers focused on Asthma and respiratory diseases (462 papers), Respiratory and Cough-Related Research (239 papers) and Allergic Rhinitis and Sensitization (152 papers). Paul M. O’Byrne collaborates with scholars based in Canada, United States and United Kingdom. Paul M. O’Byrne's co-authors include Frederick E. Hargreave, Mark D. Inman, Elizabeth F. Juniper, Peter J. Barnes, Gail M. Gauvreau, Eric D. Bateman, Penelope J. Ferrie, Derek King, Gordon Guyatt and Jeffrey M. Drazen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Paul M. O’Byrne

545 papers receiving 36.6k citations

Hit Papers

Global strategy for asthma manageme... 1981 2026 1996 2011 2007 1999 1997 2009 1993 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global strategy for asthma management and prevention: GINA executive summary
    2007 2.4k citations Eric D. Bateman, Peter J. Barnes et al. profile →
  2. Development and validation of a questionnaire to measure asthma control
    1999 1.9k citations Elizabeth F. Juniper, Paul M. O’Byrne et al. profile →
  3. Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
    1997 1.2k citations Romain Pauwels, Claes-Göran Löfdahl et al. New England Journal of Medicine profile →
  4. Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
    2009 977 citations Mark D. Inman, Paul M. O’Byrne et al. New England Journal of Medicine profile →
  5. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults
    1993 888 citations Paul M. O’Byrne et al. profile →
  6. Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
    1999 619 citations Paul M. O’Byrne et al. New England Journal of Medicine profile →
  7. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance
    1981 607 citations Paul M. O’Byrne, Elizabeth F. Juniper et al. profile →
  8. Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
    2014 587 citations Gail M. Gauvreau, Paul M. O’Byrne et al. New England Journal of Medicine profile →
  9. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial
    2003 554 citations Romain Pauwels, A. Ullman et al. profile →
  10. A summary of the new GINA strategy: a roadmap to asthma control
    2015 550 citations Eric D. Bateman, Paul M. O’Byrne et al. profile →
  11. Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma
    2001 525 citations Paul M. O’Byrne, Peter J. Barnes et al. American Journal of Respiratory and Critical Care Medicine profile →
  12. Effect of Long-term Treatment with an Inhaled Corticosteroid (Budesonide) on Airway Hyperresponsiveness and Clinical Asthma in Nonsteroid-dependent Asthmatics
    1990 458 citations Paul M. O’Byrne et al. profile →
  13. Late Asthmatic Responses
    1987 445 citations Paul M. O’Byrne et al. profile →
  14. Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma
    2018 366 citations Paul M. O’Byrne, Eric D. Bateman et al. New England Journal of Medicine profile →
  15. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia
    2015 363 citations Paul M. O’Byrne, Gail M. Gauvreau et al. profile →
  16. As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma
    2018 303 citations Eric D. Bateman, Paul M. O’Byrne et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul M. O’Byrne Canada 96 30.4k 22.7k 7.6k 6.6k 3.1k 556 38.1k
William W. Busse United States 102 26.3k 0.9× 16.8k 0.7× 8.4k 1.1× 8.2k 1.3× 3.5k 1.1× 559 34.6k
Sally E. Wenzel United States 94 27.6k 0.9× 18.8k 0.8× 6.3k 0.8× 9.3k 1.4× 4.3k 1.4× 370 34.8k
Pascal Chanez France 76 18.7k 0.6× 14.6k 0.6× 4.5k 0.6× 5.1k 0.8× 3.0k 1.0× 447 25.6k
Ian Pavord United Kingdom 93 28.4k 0.9× 24.6k 1.1× 4.3k 0.6× 6.0k 0.9× 4.1k 1.3× 608 35.3k
Christopher E. Brightling United Kingdom 86 21.1k 0.7× 17.3k 0.8× 3.6k 0.5× 7.0k 1.1× 3.1k 1.0× 496 29.1k
Eugene R. Bleecker United States 85 19.7k 0.6× 14.7k 0.6× 3.3k 0.4× 5.0k 0.8× 2.8k 0.9× 332 25.3k
Dirkje S. Postma Netherlands 89 16.6k 0.5× 18.8k 0.8× 2.5k 0.3× 3.5k 0.5× 2.0k 0.7× 592 31.2k
Robert F. Lemanske United States 71 14.8k 0.5× 10.8k 0.5× 3.1k 0.4× 3.7k 0.6× 1.3k 0.4× 209 20.6k
Romain Pauwels Belgium 51 17.6k 0.6× 18.3k 0.8× 2.9k 0.4× 3.2k 0.5× 1.2k 0.4× 146 26.3k
Stanley J. Szefler United States 81 18.2k 0.6× 14.7k 0.6× 3.1k 0.4× 2.3k 0.4× 1.4k 0.4× 487 23.9k

Countries citing papers authored by Paul M. O’Byrne

Since Specialization
Citations

This map shows the geographic impact of Paul M. O’Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. O’Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. O’Byrne more than expected).

Fields of papers citing papers by Paul M. O’Byrne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. O’Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. O’Byrne. The network helps show where Paul M. O’Byrne may publish in the future.

Co-authorship network of co-authors of Paul M. O’Byrne

This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. O’Byrne. A scholar is included among the top collaborators of Paul M. O’Byrne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. O’Byrne. Paul M. O’Byrne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dvorkin‐Gheva, Anna, Jennifer Wattie, Karen Howie, et al.. (2024). Neuromedin-U Mediates Rapid Activation of Airway Group 2 Innate Lymphoid Cells in Mild Asthma. American Journal of Respiratory and Critical Care Medicine. 210(6). 755–765. 18 indexed citations
2.
Ward, Chris, Eoin Hunt, Susan Lapthorne, et al.. (2024). Airway and Systemic Immunoglobulin Profiling and Immune Response in Adult Asthma. Lung. 202(3). 281–289. 1 indexed citations
3.
Hunt, Eoin, Chris Ward, Susan Lapthorne, et al.. (2019). The presence of Aspergillus fumigatus in asthmatic airways is not clearly related to clinical disease severity. Allergy. 75(5). 1146–1154. 17 indexed citations
4.
Busse, William W., Eric D. Bateman, Arthur L. Caplan, et al.. (2018). Combined Analysis of Asthma Safety Trials of Long-Acting β 2 -Agonists. New England Journal of Medicine. 378(26). 2497–2505. 58 indexed citations
5.
Inman, Mark D., et al.. (2001). Dose-dependent Effects of Inhaled Mometasone Furoate on Airway Function and Inflammation After Allergen Inhalation Challenge. American Journal of Respiratory and Critical Care Medicine. 164(4). 569–574. 58 indexed citations
6.
GAUVREAU, GAIL M., Krishnan Parameswaran, R. M. Watson, & Paul M. O’Byrne. (2001). Inhaled Leukotriene E4, But Not Leukotriene D4, Increased Airway Inflammatory Cells in Subjects with Atopic Asthma. American Journal of Respiratory and Critical Care Medicine. 164(8). 1495–1500. 115 indexed citations
7.
FAHY, JOHN V. & Paul M. O’Byrne. (2001). “Reactive Airways Disease”. American Journal of Respiratory and Critical Care Medicine. 163(4). 822–823. 23 indexed citations
8.
O’Byrne, Paul M., Peter J. Barnes, Roberto Rodríguez-Roisin, et al.. (2001). Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma. American Journal of Respiratory and Critical Care Medicine. 164(8). 1392–1397. 525 indexed citations breakdown →
9.
O’Byrne, Paul M.. (2000). Leukotriene Bronchoconstriction Induced by Allergen and Exercise. American Journal of Respiratory and Critical Care Medicine. 161(Supplement_1). S68–S72. 54 indexed citations
10.
Belda, J., Richard Leigh, Krishnan Parameswaran, et al.. (2000). Induced Sputum Cell Counts in Healthy Adults. American Journal of Respiratory and Critical Care Medicine. 161(2). 475–478. 312 indexed citations
11.
Killian, Kieran J., et al.. (2000). Symptom Perception during Acute Bronchoconstriction. American Journal of Respiratory and Critical Care Medicine. 162(2). 490–496. 73 indexed citations
12.
GAUVREAU, GAIL M., et al.. (2000). Exercise-induced Bronchoconstriction Does Not Cause Eosinophilic Airway Inflammation or Airway Hyperresponsiveness in Subjects with Asthma. American Journal of Respiratory and Critical Care Medicine. 162(4). 1302–1307. 47 indexed citations
13.
Kips, Johan, Brian O’Connor, Mark D. Inman, et al.. (2000). A Long-term Study of the Antiinflammatory Effect of Low-dose Budesonide Plus Formoterol versus High-dose Budesonide in Asthma. American Journal of Respiratory and Critical Care Medicine. 161(3). 996–1001. 157 indexed citations
14.
Juniper, Elizabeth F., Paul M. O’Byrne, Penelope J. Ferrie, Derek King, & Jeremy Roberts. (2000). Measuring Asthma Control. American Journal of Respiratory and Critical Care Medicine. 162(4). 1330–1334. 190 indexed citations
15.
Tattersfield, Anne E., Dirkje S. Postma, Peter J. Barnes, et al.. (1999). Exacerbations of Asthma: A Descriptive Study of 425 Severe Exacerbations. American Journal of Respiratory and Critical Care Medicine. 160(2). 594–599. 295 indexed citations
16.
O’Byrne, Paul M. & Dirkje S. Postma. (1999). The Many Faces of Airway Inflammation: Asthma and Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 159(Supplement_2). S41–S66. 142 indexed citations
17.
GAUVREAU, GAIL M., RICK M. WATSON, & Paul M. O’Byrne. (1999). Protective Effects of Inhaled PGE2 on Allergen-induced Airway Responses and Airway Inflammation. American Journal of Respiratory and Critical Care Medicine. 159(1). 31–36. 206 indexed citations
18.
GAUVREAU, GAIL M., RICK M. WATSON, & Paul M. O’Byrne. (1999). Kinetics of Allergen-Induced Airway Eosinophilic Cytokine Production and Airway Inflammation. American Journal of Respiratory and Critical Care Medicine. 160(2). 640–647. 142 indexed citations
19.
Wood, Lorna, Roma Sehmi, GAIL M. GAUVREAU, et al.. (1999). An Inhaled Corticosteroid, Budesonide, Reduces Baseline but Not Allergen-induced Increases in Bone Marrow Inflammatory Cell Progenitors in Asthmatic Subjects. American Journal of Respiratory and Critical Care Medicine. 159(5). 1457–1463. 55 indexed citations
20.
Wood, Lorna, Mark D. Inman, R. M. Watson, et al.. (1998). Changes in Bone Marrow Inflammatory Cell Progenitors after Inhaled Allergen in Asthmatic Subjects. American Journal of Respiratory and Critical Care Medicine. 157(1). 99–105. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William W. Busse Breakdown of academic impact, for papers by Sally E. Wenzel Breakdown of academic impact, for papers by Pascal Chanez Breakdown of academic impact, for papers by Ian Pavord Breakdown of academic impact, for papers by Christopher E. Brightling Breakdown of academic impact, for papers by Eugene R. Bleecker Breakdown of academic impact, for papers by Dirkje S. Postma Breakdown of academic impact, for papers by Robert F. Lemanske Breakdown of academic impact, for papers by Romain Pauwels Breakdown of academic impact, for papers by Stanley J. Szefler
Rankless by CCL
2026